Brief: Sigma-Aldrich And Genoway Expand Their CRISPR/Cas9 Strategic Alliance

genOway SA

08/09/2022 07:47

Sept 8 (Reuters) - Genoway SA  ALGEN.PA :
    * SIGMA-ALDRICH AND GENOWAY EXPAND THEIR CRISPR/CAS9
STRATEGIC
ALLIANCE
    * GENOWAY WILL CONTINUE LEADING COMMERCIALIZATION OF
SIGMA-ALDRICH
CRISPR PATENT PORTFOLIO IN FIELD OF RODENT ANIMALS
    * SIGMA-ALDRICH WILL LEAD COMMERCIALIZATION OF SIGMA-ALDRICH
CRISPR PATENT PORTFOLIO, INCLUDING PRODUCTS AND SERVICES,
OUTSIDE FIELD OF RODENT ANIMALS
    * BOTH COMPANIES WILL COLLABORATE TO OFFER "ONE-STOP SHOP"
CRISPR
SUBLICENSING SOLUTIONS

Source text for Eikon:  ID:nPresH3SPa 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))